$CBLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CLEVELAND BIOLABS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CLEVELAND BIOLABS INC. Get notifications about new insider transactions in CLEVELAND BIOLABS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2015 | CBLI | CLEVELAND BIOLABS ... | Miller Langdon L | President & CMO | Option Exercise | A | 3.00 | 10,000 | 30,000 | 10,000 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 3.20 | 6,250 | 20,000 | 12,500 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 3.20 | 6,250 | 20,000 | 6,250 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Lyons C Neil | Chief Financial Off ... | Option Exercise | A | 3.20 | 6,250 | 20,000 | 6,250 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 3.20 | 6,250 | 20,000 | 6,250 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | SALUCK RANDY S. | Director | Option Exercise | A | 3.20 | 16,000 | 51,200 | 16,000 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Option Exercise | A | 3.20 | 16,000 | 51,200 | 16,000 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | McGowan Richard | Director | Option Exercise | A | 3.20 | 16,000 | 51,200 | 16,000 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Kasimova Elena | Director | Option Exercise | A | 3.20 | 16,000 | 51,200 | 16,000 | |
Apr 24 2015 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 3.20 | 16,000 | 51,200 | 16,000 | |
Feb 27 2015 | CBLI | CLEVELAND BIOLABS ... | SALUCK RANDY S. | Director | Buy | P | 3.42 | 1,891 | 6,468 | 6,116 | 4.2 K to 6.1 K (+44.76 %) |
Feb 02 2015 | CBLI | CLEVELAND BIOLABS ... | Kasimova Elena | Director | Option Exercise | A | 4.80 | 750 | 3,600 | 750 | |
Jan 12 2015 | CBLI | CLEVELAND BIOLABS ... | BROWN JULIA R | Director | Grant | A | 0.30 | 62,500 | 18,750 | 116,482 | 54 K to 116.5 K (+115.78 %) |
Jan 12 2015 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Grant | A | 0.30 | 37,947 | 11,384 | 52,419 | 14.5 K to 52.4 K (+262.21 %) |
Oct 01 2014 | CBLI | CLEVELAND BIOLABS ... | McGowan Richard | Director | Option Exercise | A | 0.51 | 264,286 | 133,464 | 264,286 | |
Oct 01 2014 | CBLI | CLEVELAND BIOLABS ... | McGowan Richard | Director | Option Exercise | D | 0.51 | 264,286 | 133,464 | 0 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | McGowan Richard | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | McGowan Richard | Director | Option Exercise | A | 0.49 | 15,000 | 7,350 | 15,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Hoth Daniel Floyd JR | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Hoth Daniel Floyd JR | Director | Option Exercise | A | 0.49 | 15,000 | 7,350 | 15,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Polinsky Alexander | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Polinsky Alexander | Director | Option Exercise | A | 0.49 | 15,000 | 7,350 | 15,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | BROWN JULIA R | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Jun 13 2014 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 0.49 | 35,000 | 17,150 | 35,000 | |
Mar 17 2014 | CBLI | CLEVELAND BIOLABS ... | Lyons C Neil | Chief Financial Off ... | Option Exercise | A | 0.68 | 150,000 | 102,000 | 150,000 | |
Mar 17 2014 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 0.68 | 150,000 | 102,000 | 150,000 | |
Mar 17 2014 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 0.68 | 24,000 | 16,320 | 24,000 | |
Mar 17 2014 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 0.68 | 150,000 | 102,000 | 150,000 | |
Mar 17 2014 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Grant | A | 0.68 | 22,978 | 15,625 | 43,049 | 20.1 K to 43 K (+114.48 %) |
Jun 21 2013 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Grant | A | 0.00 | 14,472 | 0 | 14,472 | 0 to 14.5 K |
Jun 21 2013 | CBLI | CLEVELAND BIOLABS ... | BROWN JULIA R | Director | Grant | A | 0.00 | 15,939 | 0 | 15,939 | 0 to 15.9 K |
Jun 21 2013 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Grant | A | 0.00 | 10,102 | 0 | 41,968 | 31.9 K to 42 K (+31.70 %) |
Jun 21 2013 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Grant | A | 0.00 | 10,487 | 0 | 20,071 | 9.6 K to 20.1 K (+109.42 %) |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | BROWN JULIA R | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | SALUCK RANDY S. | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
May 23 2013 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Buy | P | 1.61 | 6,210 | 9,997 | 31,866 | 25.7 K to 31.9 K (+24.20 %) |
Jun 18 2013 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 1.58 | 35,000 | 55,300 | 35,000 | |
May 21 2013 | CBLI | CLEVELAND BIOLABS ... | SALUCK RANDY S. | Director | Buy | P | 1.60 | 3,500 | 5,613 | 84,500 | 81 K to 84.5 K (+4.32 %) |
May 15 2013 | CBLI | CLEVELAND BIOLABS ... | Lyons C Neil | Chief Financial Off ... | Option Exercise | A | 1.54 | 77,131 | 118,782 | 77,131 | |
May 15 2013 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 1.54 | 84,057 | 129,448 | 84,057 | |
May 15 2013 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Option Exercise | A | 1.54 | 81,828 | 126,015 | 81,828 | |
May 15 2013 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 1.54 | 25,000 | 38,500 | 25,000 | |
May 15 2013 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 1.54 | 104,588 | 161,066 | 104,588 | |
May 10 2013 | CBLI | CLEVELAND BIOLABS ... | SALUCK RANDY S. | Director | Option Exercise | A | 1.82 | 15,000 | 27,300 | 15,000 | |
Apr 24 2013 | CBLI | CLEVELAND BIOLABS ... | Principi Anthony | Director | Option Exercise | A | 1.96 | 15,000 | 29,400 | 15,000 | |
Apr 24 2013 | CBLI | CLEVELAND BIOLABS ... | BROWN JULIA R | Director | Option Exercise | A | 1.96 | 15,000 | 29,400 | 15,000 | |
Apr 05 2013 | CBLI | CLEVELAND BIOLABS ... | Viallet Jean | Chief Development O ... | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
Mar 18 2013 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 1.56 | 3,700 | 5,772 | 8,000 | 4.3 K to 8 K (+86.05 %) |
Oct 29 2012 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Option Exercise | A | 1.45 | 100,000 | 145,000 | 100,000 | |
Nov 28 2012 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 1.28 | 21,812 | 27,919 | 21,812 | |
Jul 05 2012 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Buy | P | 1.61 | 1,000 | 1,610 | 9,584 | 8.6 K to 9.6 K (+11.65 %) |
Sep 25 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 2.60 | 2,316 | 6,022 | 27,258 | 24.9 K to 27.3 K (+9.29 %) |
Jul 03 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 1.76 | 3,400 | 5,984 | 24,942 | 21.5 K to 24.9 K (+15.78 %) |
Jul 03 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 3.16 | 1,300 | 4,108 | 21,542 | 20.2 K to 21.5 K (+6.42 %) |
Jul 03 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 3.15 | 300 | 945 | 20,242 | 19.9 K to 20.2 K (+1.50 %) |
Jul 03 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 3.14 | 300 | 942 | 19,942 | 19.6 K to 19.9 K (+1.53 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Grant | A | 0.00 | 15,665 | 0 | 17,377 | 1.7 K to 17.4 K (+915.01 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Grant | A | 0.00 | 27,482 | 0 | 671,982 | 644.5 K to 672 K (+4.26 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Grant | A | 0.00 | 5,584 | 0 | 8,584 | 3 K to 8.6 K (+186.13 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Grant | A | 0.00 | 6,342 | 0 | 26,998 | 20.7 K to 27 K (+30.70 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Grant | A | 0.00 | 12,770 | 0 | 1,517,370 | 1.5 M to 1.5 M (+0.85 %) |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Lyons C Neil | Chief Financial Off ... | Grant | A | 0.00 | 20,273 | 0 | 20,273 | 0 to 20.3 K |
Jun 28 2012 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Grant | A | 0.00 | 8,065 | 0 | 1,176,465 | 1.2 M to 1.2 M (+0.69 %) |
Jun 19 2012 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Option Exercise | A | 1.79 | 35,000 | 62,650 | 35,000 | |
Jun 18 2012 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 1.79 | 35,000 | 62,650 | 35,000 | |
Jun 15 2012 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | Chief Executive Off ... | Option Exercise | A | 1.79 | 100,000 | 179,000 | 100,000 | |
Jun 15 2012 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Option Exercise | A | 1.79 | 35,000 | 62,650 | 35,000 | |
Jun 15 2012 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Option Exercise | A | 1.79 | 35,000 | 62,650 | 35,000 | |
Apr 06 2012 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Buy | P | 1.71 | 1,000 | 1,710 | 3,000 | 2 K to 3 K (+50.00 %) |
Mar 20 2012 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Sell | S | 2.94 | 20,000 | 58,896 | 1,168,400 | 1.2 M to 1.2 M (-1.68 %) |
Mar 20 2012 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Sell | S | 3.04 | 35,601 | 108,241 | 1,188,400 | 1.2 M to 1.2 M (-2.91 %) |
Mar 20 2012 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Sell | S | 3.12 | 44,399 | 138,636 | 1,224,001 | 1.3 M to 1.2 M (-3.50 %) |
Jan 25 2012 | CBLI | CLEVELAND BIOLABS ... | Lyons C Neil | Chief Financial Off ... | Option Exercise | A | 3.35 | 18,750 | 62,813 | 18,750 | |
Jan 25 2012 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | President | Option Exercise | A | 3.35 | 56,250 | 188,438 | 56,250 | |
Jan 25 2012 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | CEO | Option Exercise | A | 3.35 | 56,250 | 188,438 | 56,250 | |
Jan 25 2012 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 3.35 | 56,250 | 188,438 | 56,250 | |
Jan 05 2012 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Buy | P | 2.98 | 1,000 | 2,980 | 2,000 | 1,000 to 2 K (+100.00 %) |
Dec 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 2.80 | 765 | 2,142 | 19,642 | 18.9 K to 19.6 K (+4.05 %) |
Dec 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 2.79 | 1,040 | 2,902 | 18,877 | 17.8 K to 18.9 K (+5.83 %) |
Dec 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 2.76 | 100 | 276 | 17,837 | 17.7 K to 17.8 K (+0.56 %) |
Dec 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 2.73 | 200 | 546 | 17,737 | 17.5 K to 17.7 K (+1.14 %) |
Nov 08 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 3.03 | 5,000 | 15,150 | 5,000 | |
Nov 08 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Grant | A | 0.00 | 1,638 | 0 | 646,138 | 644.5 K to 646.1 K (+0.25 %) |
Oct 06 2011 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Buy | P | 2.36 | 1,000 | 2,360 | 1,000 | 0 to 1,000 |
Sep 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 3.22 | 35 | 113 | 17,537 | 17.5 K to 17.5 K (+0.20 %) |
Sep 20 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Buy | P | 3.18 | 1,846 | 5,875 | 17,502 | 15.7 K to 17.5 K (+11.79 %) |
Sep 07 2011 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO and President | Buy | P | 2.27 | 2,200 | 4,994 | 1,253,400 | 1.3 M to 1.3 M (+0.18 %) |
Aug 22 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Buy | P | 2.29 | 1,300 | 2,976 | 644,500 | 643.2 K to 644.5 K (+0.20 %) |
Aug 16 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 2.44 | 4,426 | 10,799 | 4,426 | |
Aug 16 2011 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Option Exercise | A | 2.44 | 35,000 | 85,400 | 35,000 | |
Aug 16 2011 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Option Exercise | A | 2.44 | 35,000 | 85,400 | 35,000 | |
Aug 16 2011 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 2.44 | 35,000 | 85,400 | 35,000 | |
Aug 16 2011 | CBLI | CLEVELAND BIOLABS ... | Hohn David C | Director | Option Exercise | A | 2.44 | 35,000 | 85,400 | 35,000 | |
Aug 15 2011 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Buy | P | 2.60 | 10,000 | 26,000 | 215,656 | 205.7 K to 215.7 K (+4.86 %) |
Aug 15 2011 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Buy | P | 2.60 | 5,000 | 13,000 | 227,656 | 222.7 K to 227.7 K (+2.25 %) |
Aug 15 2011 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Buy | P | 2.58 | 5,000 | 12,900 | 222,656 | 217.7 K to 222.7 K (+2.30 %) |
May 16 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 7.31 | 2,213 | 16,177 | 2,213 | |
Mar 22 2011 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Option Exercise | A | 7.16 | 149,609 | 1,071,200 | 149,609 | |
Mar 22 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 7.16 | 149,609 | 1,071,200 | 149,609 | |
Mar 22 2011 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 7.39 | 2,128 | 15,726 | 4,255 | |
Mar 22 2011 | CBLI | CLEVELAND BIOLABS ... | Marhofer John A Jr | Chief Financial Off ... | Option Exercise | A | 7.16 | 149,609 | 1,071,200 | 149,609 | |
Mar 22 2011 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 7.16 | 149,609 | 1,071,200 | 149,609 | |
Nov 22 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 6.09 | 4,255 | 25,913 | 4,255 | |
Nov 22 2010 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Buy | P | 6.15 | 10,000 | 61,500 | 27,656 | 17.7 K to 27.7 K (+56.64 %) |
Nov 22 2010 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Buy | P | 6.10 | 2,000 | 12,200 | 17,656 | 15.7 K to 17.7 K (+12.77 %) |
Sep 01 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 3.91 | 3,856 | 15,077 | 3,856 | |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | Perez Hector Daniel | Director | Option Exercise | A | 2.98 | 35,000 | 104,300 | 35,000 | |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | Perez Hector Daniel | Director | Grant | A | 0.00 | 8,389 | 0 | 12,749 | 4.4 K to 12.7 K (+192.41 %) |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Option Exercise | A | 2.98 | 35,000 | 104,300 | 35,000 | |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Grant | A | 0.00 | 8,389 | 0 | 15,656 | 7.3 K to 15.7 K (+115.44 %) |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Option Exercise | A | 2.98 | 35,000 | 104,300 | 35,000 | |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Grant | A | 0.00 | 8,389 | 0 | 15,656 | 7.3 K to 15.7 K (+115.44 %) |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Perez Hector Daniel | Director | Grant | A | 0.00 | 4,360 | 0 | 4,360 | 0 to 4.4 K |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Option Exercise | A | 2.98 | 35,000 | 104,300 | 35,000 | |
Jun 10 2010 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Grant | A | 0.00 | 8,389 | 0 | 15,656 | 7.3 K to 15.7 K (+115.44 %) |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Option Exercise | A | 3.44 | 105,000 | 361,200 | 105,000 | |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Grant | A | 0.00 | 7,267 | 0 | 7,267 | 0 to 7.3 K |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Antal James | Director | Grant | A | 0.00 | 7,267 | 0 | 7,267 | 0 to 7.3 K |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Option Exercise | A | 3.44 | 105,000 | 361,200 | 105,000 | |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | DiCorleto Paul E | Director | Grant | A | 0.00 | 7,267 | 0 | 7,267 | 0 to 7.3 K |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | KASTEN BERNARD L | Director | Grant | A | 0.00 | 7,267 | 0 | 7,267 | 0 to 7.3 K |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 3.44 | 105,000 | 361,200 | 105,000 | |
May 20 2010 | CBLI | CLEVELAND BIOLABS ... | Marhofer John A Jr | Chief Financial Off ... | Option Exercise | A | 3.44 | 105,000 | 361,200 | 105,000 | |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.53 | 200 | 706 | 1,504,600 | 1.5 M to 1.5 M (-0.01 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.56 | 100 | 356 | 1,504,800 | 1.5 M to 1.5 M (-0.01 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.51 | 290 | 1,018 | 1,504,900 | 1.5 M to 1.5 M (-0.02 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.62 | 300 | 1,086 | 1,505,190 | 1.5 M to 1.5 M (-0.02 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.60 | 900 | 3,240 | 1,505,490 | 1.5 M to 1.5 M (-0.06 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.50 | 3,010 | 10,535 | 1,506,390 | 1.5 M to 1.5 M (-0.20 %) |
May 18 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.52 | 200 | 704 | 1,509,400 | 1.5 M to 1.5 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.96 | 666 | 2,637 | 1,266,200 | 1.3 M to 1.3 M (-0.05 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.93 | 634 | 2,492 | 1,266,866 | 1.3 M to 1.3 M (-0.05 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.94 | 100 | 394 | 1,267,500 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.97 | 100 | 397 | 1,267,600 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.98 | 900 | 3,582 | 1,267,700 | 1.3 M to 1.3 M (-0.07 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.00 | 100 | 400 | 1,268,600 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.99 | 200 | 798 | 1,268,700 | 1.3 M to 1.3 M (-0.02 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.95 | 600 | 2,370 | 1,268,900 | 1.3 M to 1.3 M (-0.05 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.94 | 400 | 1,576 | 1,269,500 | 1.3 M to 1.3 M (-0.03 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.91 | 200 | 782 | 1,269,900 | 1.3 M to 1.3 M (-0.02 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.01 | 100 | 401 | 1,270,100 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.01 | 100 | 401 | 1,270,200 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.97 | 200 | 794 | 1,270,300 | 1.3 M to 1.3 M (-0.02 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.92 | 100 | 392 | 1,270,500 | 1.3 M to 1.3 M (-0.01 %) |
Apr 22 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.89 | 600 | 2,334 | 1,270,600 | 1.3 M to 1.3 M (-0.05 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.78 | 200 | 757 | 661,200 | 661.4 K to 661.2 K (-0.03 %) |